Regulatory B-cells that express high levels of STAT3 have also been identified in the draining lymph nodes of lung cancer patients and promote tumor progression by inducing angiogenesis and immunosuppression via production of IL10 [124,125]. The gene discussed is STAT3; the disease is lung carcinoma.